Conference Description

The Bone Course: Recent Advances in the Management and Treatment of Bone Diseases

This course is filled and registration is closed!

October 20, 2007
Westin Fort Lauderdale
400 Corporate Drive
Ft. Lauderdale, FL
954-772-1331

Tell a friend about this conference

See how attendees evaluated this conference

CME Credits: 3.75*

Nonrefundable registration fee: $0.

Target Audience: Primary care physicians, rheumatologists, endocrinologists, OBGYNs,and other health care providers who treat patients with bone diseases.

Program Summary:

The purpose of this course is to provide health care professionals with an authoritative review and update on the management of the most common bone diseases, including primary and secondary osteoporosis, renal osteodystrophy, Paget’s disease and bone oncology. An expert faculty (see proposed faculty below) will address state of the art approaches to prevention, diagnosis and treatment of bone disease, including a brief consideration of new drugs in development. In addition, there will be two interactive sessions with audience participation, one of which will consist of a discussion of current controversies in bone disease management and case presentations, and the other will address pitfalls on bone density measurement.

Learning Objectives:
At the conclusion of this program, participants should be able to:

1. describe the epidemiology and pathogenesis of common bone diseases
2. understand and implement current guidelines for the assessment, diagnosis and treatment of bone disease
3. explain successful measures to prevent disorders of bone and mineral metabolism
4. participate in discussion of current controversies in the management of bone diseases
5. discuss the gap between knowledge and practice in the management of bone diseases and strategies for rectifying this
6. recognize and avoid pitfalls in the use of bone densitometry
7. understand the mechanism of action of current approved therapies, as well as those in development
8. recognize the skeletal complications related to bone metastases and cancer therapy
9. identify unmet needs in the management of bone diseases and ongoing research initiatives

Agenda:
Saturday, October 20, 2007

8:00-8:15 am		Welcome and Introduction David Dempster, PhD
8:15-8:45		Postmenopausal Osteoporosis and Osteoporosis in Men Michael McClung, MD
8:45-9:15		Glucocorticoid-induced and Other Forms of Secondary Osteoporosis Michael Maricic, MD
9:15-9:45		Break
9:45-10:15		Renal Osteodystrophy Paul Miller, MD
10:15-10:45		Cancer and Bone Theresa Guise, MD
10:45-11:15		Pathophysiology of Paget’s Disease G.David Roodman, MD, PhD
11:15-12:30		Current controversies in bone mass measurement, bone disease management and case presentations Interactive Panel

Faculty:
David W. Dempster, PhD
Professor of Clinical Pathology
Columbia University, New York
Director, Regional Bone Center
Helen Hayes Hospital
West Haverstraw, New York

Theresa Guise, MD
Gerald D. Aurbach Professor of Endocrinology
Professor of Medicine, University of Virginia
Division of Endocrinology and Metabolism
Department of Medicine, Charlottesville, VA

Michael Maricic, MD
Clinical Associate Professor of Medicine
University of Arizona
Catalina Pointe Arthritis and Rheumatology Specialists, PC, Tucson, AZ

Paul Miller, MD
Clinical Professor of Medicine
University of Colorado Health Sciences Center
Medical Director
Colorado Center for Bone Research
Lakewood, CO

Michael McClung, MD
Department of Medical Education
Providence Portland Medical Center
Director, Oregon Osteoporosis Center
Portland, OR

G. David Roodman, MD, PhD
Professor of Medicine
Vice Chair for Research
School of Medicine, University of Pittsburgh
Director, Center for Bone Biology
UPMC Health System
Director, Myeloma Program at UPCI
Pittsburgh, PA

Course Director: David Dempster, PhD

Activity Director: Michelle Frisch, MPH

*Continuing Education Information
This activity has been reviewed and is acceptable for up to 3.75 Prescribed credit(s) by the American Academy of Family Physicians. The AAFP invites comments on any activity that has been approved for AAFP CME credit. Please forward your comments on the quality of this activity to cmecomment@aafp.org.

This activity has been planned and implemented in accordance with the Essentials Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the University of Massachusetts Medical School (UMMS) and the National Association for Continuing Education. The University of Massachusetts Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The University of Massachusetts Medical School designates this continuing medical education activity for a maximum of 3.75 AMA PRA Category I Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

This offering meets the requirements for 3.75 contact hours for nurses, as specified by the Massachusetts Board of Registration in Nursing (244- CMR 5.04). Each nurse should claim only those hours of credit that he/she actually spent in the educational activity.

Policy on Faculty and Provider Disclosure: It is the policy of the University of Massachusetts Medical School to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME activities sponsored by the University of Massachusetts Medical School are required to present evidenced- based data, identify and reference off-label product use and disclose all relevant financial relationships with those supporting the activity or others whose products or services are discussed. Faculty disclosure will be provided in the activity materials.

This program was supported through educational grants from the following companies: Amgen, Lilly, Merck, P&G.